Can Disinfection and Sterilization Equipment Reuse Test Reports for Overseas Registration?

FAQ Article

Can disinfection and sterilization equipment reuse test reports for overseas registration? The reuse of test reports for overseas registration of disinfection and sterilization equipment cannot be generalized. Companies should first confirm whether the product falls under the medical device regulatory scope of the target country or region, and determine the risk class and registration pathway. For existing test reports obtained under NMPA, CE, FDA, or ISO 13485 systems, it is necessary to item-by-item verify the testing standards, sample information, testing laboratory qualifications, and report validity. If the target market adopts the same international standards (such as IEC 61010 series, ISO 11135, or ISO 11137), and the testing environment and samples have not undergone substantive changes, some physicochemical and electrical safety reports may be reusable. However, biocompatibility, sterilization validation, software lifecycle, and clinical evaluation conclusions often need to be reassessed or supplemented according to local regulations. Companies should establish a core technical file library that uniformly manages original reports, raw data, translations, and gap analyses, while also confirming local agent, authorized representative, and post-market surveillance requirements. Common risks include directly submitting untranslated or unnotarized old reports, ignoring standard version differences, failing to re-conduct clinical evaluation as required by local ethical requirements, and not linking changes to test reports. It is recommended that companies engage a professional regulatory consultancy early to conduct a gap analysis, confirming which reports can be directly accepted and which require supplemental testing or reissuance, to reduce deficiency costs and registration timelines.

Published: 2026-08-27 17:11 | Updated: 2026-08-27 17:11 | Source: Compiled from AIMEILI registration practice database, medical device international registration knowledge base, and public regulatory information; specific projects should be based on the target country’s latest regulatory requirements and product documentation.

This article addresses priority issues companies need to assess in actual projects related to international medical device registration, documentation preparation, compliance pathways, and post-market maintenance.

Key Summary

Whether test reports can be reused for overseas registration of disinfection and sterilization equipment is not a one-size-fits-all answer. Companies should first confirm whether the product is regulated as a medical device in the target country or region, and determine the risk class and registration pathway. For existing test reports under NMPA, CE, FDA, or ISO 13485, each report must be checked against the testing standard, sample information, laboratory qualifications, and report validity.

If the target market adopts the same international standards (e.g., IEC 61010 series, ISO 11135, or ISO 11137), and the testing environment and samples have not changed materially, some physicochemical and electrical safety reports may be reusable. However, biocompatibility, sterilization validation, software lifecycle, and clinical evaluation conclusions often need to be reassessed or supplemented under local regulations. Companies should build a core technical file library that centrally manages original reports, raw data, translations, and gap analyses, and also confirm local agent, authorized representative, and post-market surveillance requirements.

Common risks include directly submitting untranslated or unnotarized old reports, ignoring standard version differences, failing to redo clinical evaluation in accordance with local ethics requirements, and not linking product changes to test reports. Companies are advised to commission a professional regulatory consultancy to perform a gap analysis, determining which reports can be directly accepted, which need supplemental testing, and which must be reissued, thereby reducing deficiency costs and registration timelines.

Applicable Scenarios and Core Issues

Disinfection and sterilization equipment is a product category with high technical complexity, numerous standards, and stringent regulatory requirements. Common products include steam sterilizers, ethylene oxide sterilizers, low-temperature plasma sterilizers, hydrogen peroxide sterilizers, and ultraviolet disinfection devices. After obtaining an NMPA registration certificate or CE certificate in China, companies often wish to use existing test reports directly for new registration applications in Southeast Asia, the Middle East, Latin America, or GHWP member countries, to save time and cost.

The core question is not whether the report can be reused, but which report, under which standard, is accepted by which regulatory authority through which procedure. Different countries may accept the same test report, or may require reissuance or additional verification. The key depends on product classification, risk class, the target market’s regulatory system, and the technical relevance of the report.

Companies must recognize that reuse of test reports is not a simple matter of copying and translation, but a process of evaluating the evidence chain. Regulatory authorities will review the product model, technical parameters, testing standards, testing environment, sample information, and validity period in the report. Any discrepancy may lead to deficiencies or refusal of acceptance.

Registration Decision Logic

Step 1: Determine Whether the Product Is Regulated as a Medical Device

In most countries, disinfection and sterilization equipment is classified as a medical device. However, some ultraviolet disinfection devices may be regulated as electrical appliances or Class II medical devices. Confirm the classification through official classification databases or a local agent.

Step 2: Determine Risk Class and Registration Pathway

Among GHWP member countries, Singapore, Malaysia, Thailand, and Vietnam typically classify devices into Classes A, B, C, and D. Steam sterilizers are often Class C or D, requiring significantly more technical documentation and test reports than low-risk products.

Step 3: Confirm Application Entity and Local Agent Requirements

Almost all overseas registrations require a local registrant or license holder. The applicant and manufacturer information on the test report must be logically consistent with the final certificate holder; otherwise, even a valid report may be rejected due to mismatched parties.

Step 4: Evaluate Reuse Potential of Existing Documentation

Review NMPA registration test reports, CE technical file test reports, FDA 510(k) or PMN supporting documents, ISO 13485/MDSAP certificates, and manufacturer internal validation reports. Determine item-by-item whether they cover the target market requirements.

Step 5: Confirm Localization Conversion Requirements

This includes language translation, notarization, standard difference analysis, label and instruction manual compliance, and the local agent’s responsibility for report authenticity and ongoing updates. Avoid focusing only on the report itself while ignoring supporting documents.

Materials and Evidence

Materials that may be reusable include: electrical safety test reports (e.g., IEC 60601-1 or IEC 61010 series), electromagnetic compatibility test reports, performance test reports (e.g., sterilization temperature, pressure, time, and microbial inactivation effect), and chemical material or surface coating test reports. If the product is exported to the EU with the CE mark, its reports may be accepted as baseline data by many countries, but local authorization or notarization may still be required.

Materials that generally cannot be directly reused include: biocompatibility evaluation reports (most countries require reassessment according to locally recognized standards), sterilization process validation reports (because sterilant residue and emission regulations vary by country), software lifecycle documentation (if the target market has additional cybersecurity requirements), and clinical evaluation or clinical evidence (depending on the country’s acceptance of clinical data).

The evidence checklist companies should prepare includes: original test reports and their complete test data, laboratory qualification certificates, standard version comparison tables, sample description and product model consistency statements, translated and notarized documents, declarations signed by the local agent, label and instruction manual submissions, and a post-market surveillance plan.

Change records are also necessary. If the product has undergone design changes, material changes, software version upgrades, or manufacturing site transfers since testing, a change assessment must explain why the old report remains valid, or provide supplemental difference testing.

Common Errors

• Translating all NMPA test reports and submitting them directly without verifying the target country’s acceptance of the testing standards.
• Ignoring standard version differences, e.g., the target country requires IEC 60601-1 3rd edition, but the old report is based on the 2nd edition.
• Product model or specification on the report does not match the registration application, causing regulators to question technical file consistency.
• Failing to confirm whether the testing laboratory has the qualifications recognized by the target regulator, even using reports from laboratories that are not ISO 17025 accredited.
• Providing only report summaries without raw data or attachments, making it impossible to respond to technical review inquiries.
• Directly using notified body test reports from CE certificates without required notarization or additional declarations for the target market.
• Ignoring mismatches between biological indicators in sterilization effectiveness validation reports and the target market’s microbiological standards.
• Using expired test reports as core evidence without a risk assessment.

Company Preparation Checklist

• Confirm the target country/region’s regulatory authority, classification boundary, and registration pathway, and document the official basis.
• Take inventory of all existing test reports, creating a list that includes report number, standard, version, date, testing laboratory, and sample model.
• Perform item-by-item gap analysis, marking which reports can be used directly, which require supplemental testing, and which must be reissued.
• Collect original test data, test protocols, deviation statements, and equipment calibration records to ensure a complete evidence chain.
• Arrange professional translation, and have the local agent assist in confirming official translations of terminology and standard numbers.
• Prepare a product model coverage table to ensure all intended registration models are covered by the test reports.
• Sign an agreement with the local agent clearly defining responsibilities for report authenticity, updates, and cancellation.
• Develop a post-market surveillance plan that includes adverse event reporting, periodic risk updates, and a mechanism linking test reports with design changes.

AIMEILI Perspectives

Companies often mistakenly view the “test report” as a static document, while regulators focus on the technical evidence chain behind the report. Whether an old report can be used depends on whether the product has changed, whether standards have been upgraded, whether the testing laboratory is still recognized, and whether the local agent can effectively handle inquiries.

Early in the project, do not rush to translate all reports. Instead, first clarify the minimum technical documentation requirements and review focus of the target country, conduct a gap analysis, and then invest resources in translation, notarization, and supplemental testing. This avoids spending heavily on translating reports that no one will ultimately use.

Generally reusable reports are those covering basic safety, EMC, and specific performance. Sterilization validation, biocompatibility, software lifecycle, and clinical evidence often need to be redone or supplemented locally. Companies can build a traceable archive for core technical files, ensuring original reports, standard difference analyses, change records, and translations are always linked.

The value of a local agent is not just in submitting documents, but in undertaking obligations related to certificate control, change notification, renewal management, and post-market safety updates. Companies should choose agents carefully and retain final control over technical file versions, report numbers, and registration certificate status.

For multi-country registration, it is recommended to adopt a “core report package + country-specific difference package” structure. Use universally accepted reports as the base, then add specific tests or declarations as required by each target country. This approach significantly reduces duplicate rework and deficiency risks, and avoids starting from scratch for every country.

Common Follow-up Questions

Can NMPA registration test reports be used directly for Southeast Asian registration?

Not all countries will accept them without qualification. Some countries accept NMPA-recognized test reports as technical references, but usually require translation, notarization, and may require a difference assessment against local standards. If the product was tested according to international standards and the report data is complete, reuse is more likely. If only GB standards were used, a standard comparison or supplemental testing may be required.

Can test reports under a CE certificate be used for Middle East or Latin America registration?

Most Middle Eastern and Latin American countries regard CE technical files as an important reference, but they do not directly recognize the CE certificate itself. They may require a declaration of conformity, a designated local representative, and inclusion of the CE reports as part of the registration dossier. You need to confirm whether the test reports are based on ISO/IEC standards and whether the standard versions cited are adopted by the local regulations.

What is the general validity period of test reports? Can expired reports be reused?

There is no unified global validity period for test reports. Regulators place greater emphasis on whether the product has undergone substantive changes. If the product design, materials, manufacturing process, or intended use have not changed, an expired report may still be used as supporting evidence. However, if changes have occurred, the report may become invalid even before its expiry. It is recommended to reassess at each registration and support the reasonableness of reuse with change control documents.

Continue Reading

Previous: How to Prepare Clinical Evaluation Documents for Overseas Registration of Disinfection and Sterilization Equipment?

Next: How to Use ISO 13485 Certificate for Overseas Registration of Disinfection and Sterilization Equipment?

Recommended Reading:

• Can Dental Device Test Reports Be Reused for Overseas Registration?
• Can Software Medical Device Test Reports Be Reused for Overseas Registration?
• Common Reasons for Deficiencies in Overseas Registration of Laboratory Equipment
• When Is a Registration Change Notification Required for Laboratory Equipment?
• How to Prepare Registration Documents for Overseas Registration of Disinfection and Sterilization Equipment?
• How to Organize Technical Files for Overseas Registration of Disinfection and Sterilization Equipment?

Back to FAQ Center | News | Contact AIMEILI

Content Review and Applicability Boundary

Author: AIMEILI Regulatory Editorial Department

Professional Review: AIMEILI Medical Device International Registration Project Team

Source Principle: Priority is given to official regulatory agencies, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only as auxiliary judgment.

Applicability Boundary: This article is for preliminary understanding, document preparation, and project planning. It does not replace the formal requirements, test conclusions, or legal opinions of the target country’s regulatory authority.